Profound Medical previews Q3 2026 revenue and gross margin
Profound Medical reported preliminary unaudited Q3 2026 revenue of $9.8M to $10.0M, with year-over-year growth of about 85% to 89% and gross margin expected to exceed 70%. Sequential revenue rose about 292% to 300% versus Q2 2026.